Cytosorbents (CTSO) Non-Current Deferred Tax Liability (2018 - 2021)
Cytosorbents' (CTSO) quarterly Non-Current Deferred Tax Liability came in at $183941.0 in Q4 2021, down 57.37% YoY from $431490.0 in Q4 2020, and down 57.37% on a QoQ basis from $431490.0 in Q4 2020.
Cytosorbents (CTSO) Non-Current Deferred Tax Liability (2018 - 2021) Analysis & Trends
Cytosorbents (CTSO) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $183941.0 in Q4 2021.
- Quarterly Non-Current Deferred Tax Liability fell 57.37% year-over-year to $183941.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $183941.0 (down 57.37% YoY) and the FY2021 annual result came in at $183941.0, down 57.37% from the prior year.
- Non-Current Deferred Tax Liability slipped to $183941.0 in Q4 2021, from $431490.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $431490.0 in Q4 2020 to a low of $21856.0 in Q4 2018.
- A 4-year average of $257796.0 and a median of $288919.0 in 2019 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2019 — Non-Current Deferred Tax Liability soared 1702.24% — and 2021, when it tumbled 57.37%.
- Tracing CTSO's Non-Current Deferred Tax Liability over 4 years: stood at $21856.0 in 2018, then soared by 1702.24% to $393897.0 in 2019, then gained by 9.54% to $431490.0 in 2020, then plunged by 57.37% to $183941.0 in 2021.
- The last three Non-Current Deferred Tax Liability figures came in at $183941.0 (Q4 2021), $431490.0 (Q4 2020), and $393897.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 183,941.00 |
| Dec 31, 2021 | 183,941.00 |
| Dec 31, 2020 | 431,490.00 |
| Dec 31, 2020 | 431,490.00 |
| Dec 31, 2019 | 393,897.00 |
| Dec 31, 2019 | 393,897.00 |
| Dec 31, 2018 | 21,856.00 |
| Dec 31, 2018 | 21,856.00 |